Biotechnology
Single Domain Antibody Platforms Market

Single Domain Antibody Platforms Market Size, Share, Growth, and Regional Forecast, 2025 - 2032

Single Domain Antibody Platforms Market by Platform Type (Multi-specific, Bispecific, Multivalent, Mono-specific), Animal Source (Camelids, Sharks), Application (Diagnostic Laboratories, Therapeutic Development, Research and Development Activities), End User (Diagnostic Laboratories, Clinical Laboratories, Academic and Research Institutes), and Regional Analysis from 2025 - 2032

ID: PMRREP28351

September 2025

189 Pages

Author : Pravin Rewale

Healthcare

Preview Segmentation

Key Industry Highlights

Leading Region: Europe single domain antibody platforms market is estimated to hold a share of 27.1% in 2025 as the region is adopting sdAb in point-of-care diagnostic applications.
Fast-growing Region: The single domain antibody platforms market in North America is set to hold a value share of 37.9% in 2025 as biotechnology and pharmaceutical companies are partnering with research institutions to develop sdAb-based therapies.
Leading Animal Source: In terms of animal source, the camelids category is projected to hold a share of 92.3% in 2025 as SdABs effectively penetrate tissues and bind to difficult-to-reach epitopes.
Leading Application: By application, the therapeutic development segment is expected to account for a share of 45.0% in 2025 as sdAbs are ideal for large-scale production and low-cost therapeutic applications.

Key Insights	Details
Single Domain Antibody Platforms Market Size (2025E)	US$ 35.8 Mn
Market Value Forecast (2032F)	US$ 67.2 Mn
Projected Growth (CAGR 2025 to 2032)	9.7%
Historical Market Growth (CAGR 2019 to 2024)	7.5%

global-single-domain-antibody-platforms-market-2025-2032

Get Your CustomizationGet Your Customization

Market Dynamics

Driver - Increasing Collaborations and Strategic Expansions to Boost Demand

Single domain antibodies are highly versatile and adaptable, thereby making them an invaluable tool for medical research, disease detection and treatment, and innovations in biotechnology. The medical companies are actively collaborating with research institutes, biopharmaceutical firms, and Clinical Research Organizations (CROs) to find novel applications to develop innovative products. There is an increasing focus on developing and upgrading key healthcare technologies, along with the introduction of new products and services. For instance, in December 2023, GenScript Biotech Corporation announced the expansion of its collaboration with Roche, a partnership that began in 2011 under a Laboratory Service Agreement. The expanded collaboration aimed to further drive innovation across GenScript’s portfolio of life science research tools and services globally.

Manufacturers are increasing investments in research and development to bolster innovation. They are prioritizing developing economies as these countries are showing fast growth in the single domain antibodies market share. The potential for outsourcing biotech projects has increased owing to the availability of skilled labor at affordable prices in developing nations such as China and India.

Restraints - Extended Approval Process to Emerge as a Prominent Restraint for Growth

As biologics progress through commercialization and clinical trials, regulatory requirements are likely to become more stringent. The approval of biological products in the U.S. requires a Biologics License Application (BLA). The product, as well as the process, must be validated and exclusively monitored against Critical Quality Attributes (CQAs) throughout the manufacturing process.

To gain approval, regulatory bodies must approve the end product as well as the process, CQAs, antibodies, consumable cell lines, and equipment that were used during production. The extended time associated with waiting for regulatory approvals is likely a challenge. It is necessary to use more than one animal source, as camelid species may not be readily available to all researchers due to animal husbandry because it necessitates specialized facilities. Analyzing the consistency of immunization processes like DNA immunization is also crucial to avoid the heterogeneity of immune responses. This can emerge as a key challenge to maintain process efficiency.

Opportunity - Surging Prevalence of Infectious Diseases to Create Fresh Prospects

SbAds have shown promise in targeting several viruses, including HIV, influenza, SARS-CoV-2, and Ebola. They can bind to viral proteins with high specificity, potentially leading to the development of broad-spectrum antiviral therapies that can treat an array of viral infections.

Single-domain antibody platform offers rapid response solutions for new and emerging infectious diseases owing to its quick production processes. Their stability and small size make them ideal for rapid deployment in response to pandemics or outbreaks.

SdAbs may be affordable and swift to generate compared to conventional monoclonal antibodies in preventive as well as therapeutic applications for viral infections. The requirement for antibody-based therapeutics is hence projected to rise across the globe.

Category-wise Analysis

By Animal Source, Small Size, and Superior Stability of Camelid SdAbs Makes Them Reliable

Camelids are the primary biological source of single-domain antibodies (sdAbs), accounting for around 92.3% of production. These animals possess a distinctive immune system that generates heavy-chain antibodies, from which sdAbs are derived. The small size of camelid-based sdAbs allows them to penetrate tissues more effectively and bind to hard-to-reach epitopes, making them highly valuable for targeting complex diseases. Their inherent stability enhances reliability while also simplifying handling, storage, and transport.

Camelid sdAbs are developed across multiple therapeutic indications and can be engineered into diverse formats of targeted therapeutics. Furthermore, their high specificity and compact structure make them ideal for diagnostic use, as seen in rapid infectious disease testing and medical imaging applications, including improved tumor detection.

By Application, Cardiac Surgery Segment Leads the Market

Therapeutic development represents one of the most prominent applications of single-domain antibody (sdAb) platforms, accounting for 45.0% share. SdAbs are gaining traction in this space due to their versatility, which allows them to bind multiple targets at once, thereby enhancing therapeutic potential. In addition, sdAb platforms support cost-effective and rapid manufacturing, making them more affordable and scalable compared to traditional monoclonal antibodies—an advantage for both large-scale and low-cost therapeutic applications. Their use is expanding into diverse areas, including Enzyme Replacement Therapy (ERT), where they improve enzyme delivery to lysosomes, and vaccine development, where they help boost immune responses. Moreover, their ability to cross the blood-brain barrier makes sdAbs especially valuable in addressing neurological disorders and in gene therapy applications, where they facilitate the targeted delivery of genetic material to specific tissues or cells.

global-single-domain-antibody-platforms-market-outlook-by-platform-type-2025-2032

Request Free sampleRequest Free sample

Region-wise Insights

North America Single Domain Antibody Platforms Trends

The region is anticipated to dominate with a share of 37.9% in 2025, due to rising number of immunotherapy candidates and clinical trials in North America are driving focus on immuno-oncology, where sdAbs show great promise. Their ability to conjugate with cytotoxic drugs or immune-modulating agents to create Antibody-Drug Conjugates (ADCs) is garnering attention in the cancer treatment space. For instance, The American Society of Clinical Oncology 2022 report found that federal funding provided for cancer research resulted in substantial growth in the diagnosis, treatment, and prevention of cancer. The Congress invested around US$1.25 Bn in funding for cancer research and development, further increasing the funding for the National Institute of Health (NIH), including a US$120 Mn increase in the National Cancer Institute.

Biotechnology and pharmaceutical companies in North America are entering into partnerships with research institutions and biotech firms to develop sdAb-based therapies. Such collaborations are predicted to accelerate the development and commercialization of SdAb products.

Asia Pacific Single Domain Antibody Platforms Market Trends

Asia Pacific single-domain antibody (sdAb) platforms market is emerging as a dynamic growth hub, fueled by rapid advancements in biotechnology and rising demand for affordable biologics. Countries such as China, India, South Korea, and Japan are investing heavily in research infrastructure, fostering collaborations between academic institutes and biopharma companies to accelerate sdAb innovation. Increasing cancer prevalence, coupled with a high burden of infectious diseases, is driving demand for targeted, patient-friendly therapeutics. Local players are leveraging sdAb’s cost-efficient production and stability to expand into oral formulations and diagnostic applications. Government support, clinical trial expansions, and cross-border partnerships are further positioning Asia–Pacific as a key contributor to global sdAb development, with strong potential for both therapeutic and diagnostic breakthroughs.

global-single-domain-antibody-platforms-market-outlook-by-region-2025-2032

Competitive Landscape

Single-domain antibody manufacturers are increasingly concentrating on innovative drug development and securing product patents as strategic measures to maximize market revenue. To strengthen their competitive position, leading players are actively pursuing collaborations with research institutes, biopharma companies, and healthcare providers. These partnerships not only accelerate product innovation but also expand clinical validation, regulatory approvals, and commercialization opportunities.

Key Industry Developments

In April 2025, ProBio presented at the American Association for Cancer Research? (AACR) 116th Annual Meeting, which was held from April 25 to 30, 2025, at the McCormick Place Convention Center in Chicago, Illinois.
In March 2024, GenScript Biotech Corporation, based in the U.S., announced the expansion of its collaboration with Roche. Their partnership began in 2011 under a Laboratory Service Agreement. The expanded collaboration is aimed to further drive innovation across GenScript’s portfolio of life science research tools and services globally.
In August 2024, Rockland Immunochemicals, based in the U.S., partnered with The Jackson Laboratory (JAX) and antibodies-online GmbH (ABO) to exclusively manufacture and distribute highly characterized Fc Neonatal Receptor (FcRn) antibodies.

Companies Covered in Single Domain Antibody Platforms Market

GenScript Biotech Corporation
Creative Biolab
Synbio Technologies
ProSci Incorporated
Antibody Design Labs
Fusion BioLabs, LLC (Oak BioSciences, Inc.)
Rockland Immunochemicals, Inc.
Hybrigenics Services
NeoClone
Kaneka Eurogentec S.A
ProteoGenix
ProBio
Other

Frequently Asked Questions

The global market is projected to be valued at US$ 67.2 Mn in 2025.

Their small size, high tissue penetration, stability, and ability to bind hard-to-reach epitopes make sdAbs more versatile than conventional monoclonal antibodies.

The global market is poised to witness a CAGR of 9.7% between 2025 and 2032.

The ability to conjugate with cytotoxic drugs, radioactive isotopes, and gene-editing tools creates scope for next-generation precision therapeutics.

GenScript Biotech Corporation, Creative Biolab, Synbio Technologies, ProSci Incorporated, and others

Report Attribute	Details
Historical Data/Actuals	2019 - 2024
Forecast Period	2025 - 2032
Market Analysis	Value: US$ Mn
Geographical Coverage	North America Europe East Asia South Asia and Oceania Middle East and Africa Latin America
Segmental Coverage	By Platform Type By Animal Source By Application By End-User By Region
Competitive Analysis	GenScript Biotech Corporation Creative Biolab Synbio Technologies ProSci Incorporated Antibody Design Labs Fusion BioLabs, LLC (Oak BioSciences, Inc.) Rockland Immunochemicals, Inc. Hybrigenics Services NeoClone Kaneka Eurogentec S.A ProteoGenix ProBio Other
Report Highlights	Market Forecast and Trends Competitive Intelligence & Share Analysis Growth Factors and Challenges Strategic Growth Initiatives Future Opportunities and Revenue Pockets Industry Market Analysis Tools ?

Top-Down Market Sizing	Bottom-Up Market Sizing
Universe Definition: Total global/regional market identification	Unit Economics: Average transaction values, purchase frequencies, customer lifecycle
Segmentation Filters: Geographic, demographic, and behavioral constraints	Customer Segmentation: Detailed buyer persona development and sizing
Market Share Analysis: Competitive landscape assessment and share allocation	Penetration Analysis: Market penetration rates by segment and geography
Growth Rate Application: Historical trends and forward-looking growth assumptions	Scaling Methodology: Extrapolation techniques with confidence intervals

Interested in this report?

Request customization, ask for expert consulting, access a sample report, or simply express your interest—our team will assist you with the right insights and solutions.

Request Custom VersionRequest Custom Version

Clients

Media Citation

Get In Touch

Loading page data

Please wait a moment

Key Insights

Details

Single Domain Antibody Platforms Market Size (2025E)

US$ 35.8 Mn

Market Value Forecast (2032F)

US$ 67.2 Mn

Projected Growth (CAGR 2025 to 2032)

9.7%

Historical Market Growth (CAGR 2019 to 2024)

7.5%

Report Attribute	Details
Historical Data/Actuals	2019 - 2024
Forecast Period	2025 - 2032
Market Analysis	Value: US$ Mn
Geographical Coverage	North America Europe East Asia South Asia and Oceania Middle East and Africa Latin America
Segmental Coverage	By Platform Type By Animal Source By Application By End-User By Region
Competitive Analysis	GenScript Biotech Corporation Creative Biolab Synbio Technologies ProSci Incorporated Antibody Design Labs Fusion BioLabs, LLC (Oak BioSciences, Inc.) Rockland Immunochemicals, Inc. Hybrigenics Services NeoClone Kaneka Eurogentec S.A ProteoGenix ProBio Other
Report Highlights	Market Forecast and Trends Competitive Intelligence & Share Analysis Growth Factors and Challenges Strategic Growth Initiatives Future Opportunities and Revenue Pockets Industry Market Analysis Tools ?

Executive Summary
1. Global Single Domain Antibody Platforms Market Snapshot, 2025 and 2032
2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
3. Key Market Trends
4. Future Market Projections
5. Premium Market Insights
6. Industry Developments and Key Market Events
7. PMR Analysis and Recommendations
Market Overview
1. Market Scope and Definition
2. Market Dynamics
  1. Drivers
  2. Restraints
  3. Opportunity
  4. Challenges
  5. Key Trends
3. Macro-Economic Factors
  1. Global Sectorial Outlook
  2. Global GDP Growth Outlook
4. COVID-19 Impact Analysis
5. Forecast Factors - Relevance and Impact
Value Added Insights
1. Platform Adoption Analysis
2. Value Chain Analysis
3. Key Deals and Mergers
4. PESTLE Analysis
5. Porter’s Five Force Analysis
Global Single Domain Antibody Platforms Market Outlook:
1. Key Highlights
  1. Market Size (US$ Mn) and Y-o-Y Growth
  2. Absolute $ Opportunity
2. Market Size (US$ Mn) Analysis and Forecast
  1. Historical Market Size (US$ Mn) Analysis, 2019-2024
  2. Market Size (US$ Mn) Analysis and Forecast, 2025-2032
3. Global Single Domain Antibody Platforms Market Outlook: Platform Type
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, By Platform Type, 2019 - 2024
  3. Market Size (US$ Mn) Analysis and Forecast, By Platform Type, 2025 - 2032
    1. Multi-specific Single Domain Antibody
    2. Bispecific Single Domain Antibody
    3. Multivalent Single Domain Antibody
    4. Mono-specific Single Domain Antibody
  4. Market Attractiveness Analysis: Cause
4. Global Single Domain Antibody Platforms Market Outlook: Animal Source
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, By Animal Source, 2019 - 2024
  3. Market Size (US$ Mn) Analysis and Forecast, By Animal Source, 2025 - 2032
    1. Camelids
      1. Camels
      2. Llama
      3. Alpacas
    2. Sharks
  4. Market Attractiveness Analysis: Animal Source
5. Global Single Domain Antibody Platforms Market Outlook: Application
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, By Application, 2019 - 2024
  3. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
    1. Diagnostic Laboratories
    2. Therapeutic Development
    3. Research and Development Activities
  4. Market Attractiveness Analysis: Application
6. Global Single Domain Antibody Platforms Market Outlook: End User
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, By End User, 2019 - 2024
  3. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
    1. Diagnostic Laboratories
    2. Clinical Laboratories
    3. Academic and Research Institutes
    4. Pharmaceutical and Biotechnology Companies
  4. Market Attractiveness Analysis: End User
Global Single Domain Antibody Platforms Market Outlook: Region
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Region, 2019 - 2024
3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2025 - 2032
  1. North America
  2. Europe
  3. East Asia
  4. South Asia and Oceania
  5. Latin America
  6. Middle East & Africa
4. Market Attractiveness Analysis: Region
North America Single Domain Antibody Platforms Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
  1. By Country
  2. By Platform Type
  3. By Animal Source
  4. By Application
  5. By End User
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
  1. U.S.
  2. Canada
4. Market Size (US$ Mn) Analysis and Forecast, By Platform Type, 2025 - 2032
  1. Multi-specific Single Domain Antibody
  2. Bispecific Single Domain Antibody
  3. Multivalent Single Domain Antibody
  4. Mono-specific Single Domain Antibody
5. Market Size (US$ Mn) Analysis and Forecast, By Animal Source, 2025 - 2032
  1. Camelids
    1. Camels
    2. Llama
    3. Alpacas
  2. Sharks
6. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
  1. Diagnostic Laboratories
  2. Therapeutic Development
  3. Research and Development Activities
7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
  1. Diagnostic Laboratories
  2. Clinical Laboratories
  3. Academic and Research Institutes
  4. Pharmaceutical and Biotechnology Companies
8. Market Attractiveness Analysis
Europe Single Domain Antibody Platforms Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
  1. By Country
  2. By Platform Type
  3. By Animal Source
  4. By Application
  5. By End User
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
  1. Germany
  2. France
  3. U.K.
  4. Italy
  5. Spain
  6. Russia
  7. Türkiye
  8. Rest of Europe
4. Market Size (US$ Mn) Analysis and Forecast, By Platform Type, 2025 - 2032
  1. Multi-specific Single Domain Antibody
  2. Bispecific Single Domain Antibody
  3. Multivalent Single Domain Antibody
  4. Mono-specific Single Domain Antibody
5. Market Size (US$ Mn) Analysis and Forecast, By Animal Source, 2025 - 2032
  1. Camelids
    1. Camels
    2. Llama
    3. Alpacas
  2. Sharks
6. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
  1. Diagnostic Laboratories
  2. Therapeutic Development
  3. Research and Development Activities
7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
  1. Diagnostic Laboratories
  2. Clinical Laboratories
  3. Academic and Research Institutes
  4. Pharmaceutical and Biotechnology Companies
8. Market Attractiveness Analysis
East Asia Single Domain Antibody Platforms Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
  1. By Country
  2. By Platform Type
  3. By Animal Source
  4. By Application
  5. By End User
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
  1. China
  2. Japan
  3. South Korea
4. Market Size (US$ Mn) Analysis and Forecast, By Platform Type, 2025 - 2032
  1. Multi-specific Single Domain Antibody
  2. Bispecific Single Domain Antibody
  3. Multivalent Single Domain Antibody
  4. Mono-specific Single Domain Antibody
5. Market Size (US$ Mn) Analysis and Forecast, By Animal Source, 2025 - 2032
  1. Camelids
    1. Camels
    2. Llama
    3. Alpacas
  2. Sharks
6. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
  1. Diagnostic Laboratories
  2. Therapeutic Development
  3. Research and Development Activities
7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
  1. Diagnostic Laboratories
  2. Clinical Laboratories
  3. Academic and Research Institutes
  4. Pharmaceutical and Biotechnology Companies
8. Market Attractiveness Analysis
South Asia & Oceania Single Domain Antibody Platforms Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
  1. By Country
  2. By Platform Type
  3. By Animal Source
  4. By Application
  5. By End User
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
  1. India
  2. Southeast Asia
  3. ANZ
  4. Rest of South Asia & Oceania
4. Market Size (US$ Mn) Analysis and Forecast, By Platform Type, 2025 - 2032
  1. Multi-specific Single Domain Antibody
  2. Bispecific Single Domain Antibody
  3. Multivalent Single Domain Antibody
  4. Mono-specific Single Domain Antibody
5. Market Size (US$ Mn) Analysis and Forecast, By Animal Source, 2025 - 2032
  1. Camelids
    1. Camels
    2. Llama
    3. Alpacas
  2. Sharks
6. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
  1. Diagnostic Laboratories
  2. Therapeutic Development
  3. Research and Development Activities
7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
  1. Diagnostic Laboratories
  2. Clinical Laboratories
  3. Academic and Research Institutes
  4. Pharmaceutical and Biotechnology Companies
8. Market Attractiveness Analysis
Latin America Single Domain Antibody Platforms Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
  1. By Country
  2. By Platform Type
  3. By Animal Source
  4. By Application
  5. By End User
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
  1. Brazil
  2. Mexico
  3. Rest of Latin America
4. Market Size (US$ Mn) Analysis and Forecast, By Platform Type, 2025 - 2032
  1. Multi-specific Single Domain Antibody
  2. Bispecific Single Domain Antibody
  3. Multivalent Single Domain Antibody
  4. Mono-specific Single Domain Antibody
5. Market Size (US$ Mn) Analysis and Forecast, By Animal Source, 2025 - 2032
  1. Camelids
    1. Camels
    2. Llama
    3. Alpacas
  2. Sharks
6. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
  1. Diagnostic Laboratories
  2. Therapeutic Development
  3. Research and Development Activities
7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
  1. Diagnostic Laboratories
  2. Clinical Laboratories
  3. Academic and Research Institutes
  4. Pharmaceutical and Biotechnology Companies
8. Market Attractiveness Analysis
Middle East & Africa Single Domain Antibody Platforms Market Outlook:
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
  1. By Country
  2. By Platform Type
  3. By Animal Source
  4. By Application
  5. By End User
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
  1. GCC Countries
  2. Egypt
  3. South Africa
  4. Northern Africa
  5. Rest of Middle East & Africa
4. Market Size (US$ Mn) Analysis and Forecast, By Platform Type, 2025 - 2032
  1. Multi-specific Single Domain Antibody
  2. Bispecific Single Domain Antibody
  3. Multivalent Single Domain Antibody
  4. Mono-specific Single Domain Antibody
5. Market Size (US$ Mn) Analysis and Forecast, By Animal Source, 2025 - 2032
  1. Camelids
    1. Camels
    2. Llama
    3. Alpacas
  2. Sharks
6. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
  1. Diagnostic Laboratories
  2. Therapeutic Development
  3. Research and Development Activities
7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025 - 2032
  1. Diagnostic Laboratories
  2. Clinical Laboratories
  3. Academic and Research Institutes
  4. Pharmaceutical and Biotechnology Companies
8. Market Attractiveness Analysis
Competition Landscape
1. Market Share Analysis, 2024
2. Market Structure
  1. Competition Intensity Mapping By Market
  2. Competition Dashboard
3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  1. GenScript Biotech Corporation
    1. Overview
    2. Segments and Product Types
    3. Key Financials
    4. Market Developments
    5. Market Strategy
  2. Creative Biolab
  3. Synbio Technologies
  4. ProSci Incorporated
  5. Antibody Design Labs
  6. Fusion BioLabs, LLC (Oak BioSciences, Inc.)
  7. Rockland Immunochemicals, Inc.
  8. Hybrigenics Services
  9. NeoClone
  10. Kaneka Eurogentec S.A
  11. ProteoGenix
  12. Others
Appendix
1. Research Methodology
2. Research Assumptions
3. Acronyms and Abbreviations

Single Domain Antibody Platforms Market Size, Share, Growth, and Regional Forecast, 2025 - 2032